GSA CAPITAL PARTNERS LLP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$273
-80.4%
3,785
-81.8%
0.03%
-84.4%
Q4 2022$1,392
-99.8%
20,835
+221.5%
0.17%
+68.0%
Q3 2020$618,000
+11.8%
6,480
+22.2%
0.10%
+60.9%
Q4 2019$553,000
+63.6%
5,302
+55.9%
0.06%
+39.1%
Q3 2019$338,000
-71.7%
3,400
-67.5%
0.05%
-65.7%
Q2 2019$1,193,000
+27.3%
10,447
+40.2%
0.13%
+41.1%
Q1 2019$937,000
-24.4%
7,453
-18.4%
0.10%
-33.6%
Q4 2018$1,239,000
-19.8%
9,133
+62.4%
0.14%
+68.2%
Q3 2018$1,544,000
-0.1%
5,624
-24.6%
0.08%
+10.4%
Q2 2018$1,546,000
-38.0%
7,462
-50.6%
0.08%
-41.7%
Q1 2018$2,494,000
+32.0%
15,101
+9.4%
0.13%
+14.8%
Q4 2017$1,890,000
+93.8%
13,800
+51.6%
0.12%
+85.5%
Q1 2016$975,000
+0.3%
9,105
+1.6%
0.06%
+29.2%
Q4 2015$972,000
-9.9%
8,961
-28.9%
0.05%
-9.4%
Q3 2015$1,079,000
-43.7%
12,600
-33.7%
0.05%
-28.4%
Q2 2015$1,917,000
+189.1%
19,000
+120.9%
0.07%
+184.6%
Q1 2015$663,0008,6000.03%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders